NHO Shizuoka Institute of Epilepsy and Neurological Disorders

Shizuoka 420-8688

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease

Studies at this site

• A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD) — Stopped early
• Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) — Stopped early
• A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) — Stopped early